L, Z., P, K., LA, K., JM, Z., A, C., H, I., . . . R, S. (2022). Variants in ALDH1A2 reveal an anti-inflammatory role for retinoic acid and a new class of disease-modifying drugs in osteoarthritis. Science translational medicine, 14(676), eabm4054. https://doi.org/10.1126/scitranslmed.abm4054
Chicago Style (17th ed.) CitationL, Zhu, et al. "Variants in ALDH1A2 Reveal an Anti-inflammatory Role for Retinoic Acid and a New Class of Disease-modifying Drugs in Osteoarthritis." Science Translational Medicine 14, no. 676 (2022): eabm4054. https://doi.org/10.1126/scitranslmed.abm4054.
MLA (9th ed.) CitationL, Zhu, et al. "Variants in ALDH1A2 Reveal an Anti-inflammatory Role for Retinoic Acid and a New Class of Disease-modifying Drugs in Osteoarthritis." Science Translational Medicine, vol. 14, no. 676, 2022, p. eabm4054, https://doi.org/10.1126/scitranslmed.abm4054.